RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX)

CUSIP: 75629V104

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
+680,532
Put/Call ratio
141%
SEC-reported price per share
$7.16
Number of holders
124
Value change
-$12,978,444
Number of buys
61
Open additional details 1 more signal available
Number of sells
55
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
525,448,476

Security key

75629V104

Report period

Q1 2022

Institutions

124

Top holders

10

Ownership snapshot

Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F Lead comparable stake: 65% Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 65%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership Top 5
VIKING GLOBAL INVESTORS LP 65%
GENERAL ATLANTIC, L.P. 22%
Senator Investment Group LP 15%
Anchorage Capital Group, L.L.C. 13%
Obvious Management Services, L.L.C. 1.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VIKING GLOBAL INVESTORS LP
13F
Company
13F
65%
$2,817,548,000
339,055,144 shares
31 Dec 2021
GENERAL ATLANTIC, L.P.
13F
Company
13F
22%
$927,116,000
111,566,297 shares
31 Dec 2021
Senator Investment Group LP
13F
Company
13F
15%
$565,156,000
76,595,199 shares
31 Dec 2021
Anchorage Capital Group, L.L.C.
13F
Company
13F
13%
$574,706,000
69,158,354 shares
31 Dec 2021
Obvious Management Services, L.L.C.
13F
Company
13F
1.1%
$102,397,000
5,977,631 shares
31 Dec 2021
Data Collective IV GP, LLC
13F
Company
13F
1.1%
$101,771,000
5,941,120 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
124
Shares
95,043,699
Rows available
124
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
124
Q1 2022 holders
124
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .